View of QBD-BASED RP-UPLC METHOD DEVELOPMENT AND VALIDATION FOR THE SIMULTANEOUS ESTIMATION OF ATEZOLIZUMAB AND HYALURONIDASE IN CANCER DRUG FORMULATIONS

Return to Article Details QBD-BASED RP-UPLC METHOD DEVELOPMENT AND VALIDATION FOR THE SIMULTANEOUS ESTIMATION OF ATEZOLIZUMAB AND HYALURONIDASE IN CANCER DRUG FORMULATIONS Download Download PDF